PEPT.US REX Peptide ETF
- Market cap
- -
- P/E
- 18.4x
- P/B
- -
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Is PEPT.US undervalued?
Graham numberThe Graham number of REX Peptide ETF cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
REX Peptide ETF fundamental analysis
No fundamental analysis for REX Peptide ETF yet.
REX Peptide ETF stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About REX Peptide ETF
It tracks the investment results, before fees and expenses, of the VettaFi Peptide Index" (the "Index"), which is designed to track the performance of equity securities of companies that are strategically positioned to advance the development, manufacturing, and commercial adoption of peptide-based products"including therapeutics, supplements, cosmetics, and medical devices"along with the enabling technologies essential for peptides. The fund is non-diversified.
Full company profileFinancial statements of REX Peptide ETF are not available yet.
REX Peptide ETF dividends
REX Peptide ETF has not paid dividends in the last 1 fiscal years.
Who owns REX Peptide ETF
Ownership data of REX Peptide ETF is not available yet.
REX Peptide ETF company profile
- Company name
- REX Peptide ETF
- Ticker
- PEPT.US
- Exchange
- USA Stocks
- Listed since
- Oct 14, 2026
- Sector
- Other
- Industry
- Other
- Address
- Website
- -
About REX Peptide ETF
It tracks the investment results, before fees and expenses, of the VettaFi Peptide Index" (the "Index"), which is designed to track the performance of equity securities of companies that are strategically positioned to advance the development, manufacturing, and commercial adoption of peptide-based products"including therapeutics, supplements, cosmetics, and medical devices"along with the enabling technologies essential for peptides. The fund is non-diversified.